chrisvoncsefalvay/vaers-outcomes huggingface dataset:
B: Patient has history of allergies to shellfish and "other foods", none of which previously recorded in PowerChart, per patient, "spoke to MD, OK to get vaccine but prefers a 30 minute observation". Patient reported previous history of anaphylaxis requiring Epi Pen. Patient reported onset of nausea and throat itchiness to RN, further assessment by additional RN and supervisors. Due to progressing symptoms
Patient called pharmacy to report a rash and erythema at and around injection site. I thought that she may have been experiencing Covid Arm. I suggested that patient use OTC pain reliever/fever reducer to help with the discomfort as well as oral Benadryl.  Patient presented back into the pharmacy 6 days after vaccination; She had drawn a circle around the rash area and it had continued to spread beyond the margins defined by patient. At this time, I recommended that the patient visit an urgent care/ER so that a physician could take a look at it as it had still not improved even after OTC remedies and time.
Presented to ED on 8/27/21 with fever, body aches, cough, exertional shortness of breath and loss of appetite. On arrival to ED, her oxygen saturation was reported to be 93% on room air and she was placed on oxygen. She had temperature 100.4 in ED. Had normal WBC count and renal function on labs. Tested positive for covid 19. CTA chest showed stable 5 mm right apical pulmonary nodule and was negative for pulmonary embolus or aortic dissection. Patient was admitted on Decadron in droplet plus isolation. Patient was weaned off oxygen on arrival to the floor. Patient is stable on room air over the past 48 hours with oxygen saturations 96-98%. She is afebrile. Complains of nausea but no vomiting. Tolerating oral diet.
Puffy eyes; Itching; This spontaneous case was reported by a consumer and describes the occurrence of PERIORBITAL SWELLING (Puffy eyes) and PRURITUS (Itching) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication.   On 21-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced PERIORBITAL SWELLING (Puffy eyes) and PRURITUS (Itching). At the time of the report, PERIORBITAL SWELLING (Puffy eyes) and PRURITUS (Itching) outcome was unknown.            Treatment information was not provided.
Invalid age of 17; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Invalid age of 17) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 021B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Invalid age of 17). On 06-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Invalid age of 17) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment medications were provided.  Patient did not experience any adverse event.   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: New reporter information. Updated Patient demographics. Second dose details updated.
Severe pain at injection site radiating throughout arm.  Very slight erythema and edema. Required IV narcotics for pain control. Follow up w/ PCP Dr 07/12/2012.
Moderna COVID-19 Vaccine EUA Began ~11 hours after injection with dizziness at bedtime (11 pm). Woke up around 3 am with a slight fever (100 degrees), achy muscles and joints, muscle weakness, dizziness and headache.  Drank a glass of water, put gel ice pack on forehead, back of neck, injection site (very sore.) Went back to bed around 4 am, woke up again around 6, same symptoms, drank some more water and went back to bed again - very tired.  Got up around 9 am, still feeling bad but fever was a little lower - 99.6.  Fell asleep on the couch twice that day, took 1 ibuprofen around 3 pm.  Reduced appetite that day. Fever gone by night time.  Following day, ~48 hours post-injection, only symptom was continued dizziness.  Some dizziness still  on day 3, very slight on day 4.
pt recvd vax;to er & c/o itching all over;SOB,whelps;tightness in throat;had TD approx 5 1/2 hrs earlier;dph IV,solumedrol IV given;condition improved & pt discharged from er;
Medical Assistant took the wrong vaccine out of the fridge and administered it to the baby.  There have been no reported adverse side effects reported by parent.  Patient should have received a Hib vaccine
Child vaccinated for varicella 4/7/98 confirmed case of varicella on 6/17/03.
This spontaneous report as received from a nurse refers to an unspecified number of patients of unknown age and gender. Since April 2014 the patients were vaccinated with an improperly stored dose of GARDASIL (dose, lot# and route of administration were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Pt admitted to Hospital 5/20 (seen in ER 5/19 and transferred) for Intussusception  3mo p/w bloody stool x2 and +intusseception on US last night at 8pm. The first symptom was increased crying and fussiness 2 nights ago but was still eating ok. 24 hours ago had blood in stool. Later on yesterday had anther BM with more blood. Decreased appetite for the last 16 hours.   had 5cm RUQ intussusception. Sent here. No vomiting. No distress. Only pulled legs to chest when examined at UC. The US was at approx 8PM last night.
Shaking/shivering, fever, nausea, loss of feeling in arms and legs, extreme pain at injection site.
Fever; Body aches; Ankles pain; Knees pain; Hip pain; Unable to lift injected site arm; Face swelling; Tingling of feet and hands; Throwing up; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 27Jul2021 at 09:30 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had known allergies to hay fever, opioids and some fruit. Concomitant medications included vitamins. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 28Jun2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 28Jul2021 at 06:00, the patient experienced fever, body aches, ankles, knees pain, hip pain, unable to lift injected site arm, face swelling, tingling of feet, hands and throwing up. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events fever, body aches, ankles, knees pain, hip pain, unable to lift injected site arm, face swelling, tingling of feet, hands and throwing up was recovering at the time of this report.   The batch/lot numbers for, BNT162b2, were not provided and will be requested during follow up.
Possible adverse event:  Blackened Left eye with no trauma, no pain, no swelling (slightly puffy)
Morning after  Could not go to work  And I have worked 30 years without one sick day. Low grade fever in am with shaking but not cold. Started around 6 AM by 9 AM couldn't stand  very weak  slightly lightheaded    Threw up till almost choking.  At noon my temp hit  103.7   Took tylenol all AM and wasn't lowering temp.  That was the highest temp  Then gradually began to  come down   At 5:00 PM temp at 100 and able to put soup down.  Woke up  4 AM next day in  total sweat that had to move to other side of bed  Soaked but felt OK   On 23rd  Got headache above right eye to side of frontal lobe,   Not any strong headache at all   Dull  Like a 2 out of 10.  My concern is I still have the exact same headache as I did three weeks ago  Not a smidgen lower at all  SAME.  And I booked second vaccine for Sat 2/27th    I am concerned as I have heard second can be worse.   I have never had the flu and this was my first ever vaccine of any kind    Please advise
PATIENT'S WIFE REPORTS THAT, "IT FELT LIKE HIS THROAT WAS CLOSING X 7 HOURS, THEN CLEARED UP". PATIENT DID NOT TAKE ANY MEDICATIONS FOR HIS SYMPTOMS. DID NOT GO TO AN ED OR DOCTORS OFFICE. PATIENT'S WIFE CALLED THEIR PCP, AND REPORTED TO A NURSE THERE. SHE WAS THEN TOLD TO CALL HEALTH DEPARTMENT AND REPORT IT TO US. PATIENT'S WIFE REPORTS THAT HE DOES HAVE AN ALLERGIC REACTION TO ANTS SOMETIMES, BUT NOTHING ELSE.
An online magazine reported that the mother of a patient said that her daughter was vaccinated with a dose of GARDASIL. It was reported that the patient was adversely injured from GARDASIL. This is one of several reports received from the same source. No further information is available.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 07-JUL-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Information has been received from a medical assistant concerning her daughter who on an unknown date was vaccinated with her first dose of GARDASIL (lot# unspecified). 1 hour after administration, her daughter experienced a seizure. It was unknown if her daughter had sought any medical attention. At the time of report, the outcome of the adverse event was unknown. Upon internal review, seizure was determined to be an other important medical event. The patient's brother experienced autism after received the first dose of MMR II (WAES#1110USA01810). Additional information has been requested.
Information has been received from a pharmacist concerning a female pt who on approximately 25SEP2003 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the pt developed an intense rash and hives at the injection site. Unspecified medical attention was sought and the pt was treated with Benadryl and the hives went away. The pharmacist did not know what dose number this was for the vaccine and could not provide any follow up information because he did not have access to pt information. No product quality complaint was involved. Additional information has been requested.
Neurological consequences; This spontaneous case was reported by a patient family member or friend and describes the occurrence of NERVOUS SYSTEM DISORDER (Neurological consequences) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVOUS SYSTEM DISORDER (Neurological consequences). At the time of the report, NERVOUS SYSTEM DISORDER (Neurological consequences) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported.  No treatment medication details was reported.   This case was linked to US-MODERNATX, INC.-MOD-2022-675055, US-MODERNATX, INC.-MOD-2022-675276 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2022-675055:Patient  US-MODERNATX, INC.-MOD-2022-675276:Reporter's case
Swelling at the site over 3 inches in diameter, warm to the touch, pain in joints of elbow and wrist, pain in arm pit area.
Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 76 years old female patient. Information regarding medical history, concurrent conditions, or concomitant medications was not provided.   On or about 24-OCT-2012, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified), for the long-term prevention of shingles and zoster-related conditions.        On an unknown date, the patient experienced shingles. On an unspecified date, the patient was treated by a healthcare provider for shingles. The outcome of herpes zoster was unknown. The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).  Additional information has been requested.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On an unknown date in 2016, a pharmacist at a pharmacy administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 05-MAY-2017, the patient was treated by a healthcare provider at a hospital for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the zoster vaccine live (ZOSTAVAX) vaccine, and suffered serious physical, emotional, and economic damages as a result of his injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Immediate dizziness. Arm felt like dead weight. Had trouble driving to waiting area. Within 20 minutes, chest, neck, arms, and face tightened, I couldn?t move my arms, paramedics found blood pressure to be very high. Was light headed for 48 hours after. Almost fell over multiple times. Arms and legs very heavy and tired easily.  On 4/21/2021 my leg cramped up and went numb. Week later my chest constricted with same issue from injection day. Went to hospital. Blood pressure again elevated.  Concerned of a blood clot, did chest mri and ultrasound of blood vessel in leg. No blood clot found, but new lesions in chest were found and no explanation of leg issues.  As of today?s date, no one can figure out why my right leg is numb from mid thigh down, but has major pain and causing me not to be able to walk and go up stairs.  Feels like a constant charley horse in my calf with pain radiating through my knee and up my thigh. No injury was sustained. It happened all of the sudden while laying on the couch reading.  I?ve seen regular doc, pt specialist, sports med doc, headed to a spine specialist next. No explanation of strange pain and numbness.
I woke up two days in a row with a sore throat.  Then, sore throat went away.  Then, I started getting a headache.  Then, I called the doctor.  She said it sounded like a sinus infection and gave me a prescription for it.
p/ pt recv vax on 7/98 in 8/98 pt exp urticaria
itchy throat; itchy throat/back of the tongue reaction; This is a spontaneous report from a contactable physician. This physician reported similar events for two patients. This is the first report.  A female patient of an unspecified age (reported as 50, unit unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not provided), via an unspecified route of administration on 17Dec2020 22:00 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced itchy throat/back of the tongue reaction. No rash, then they gave her epi 10, ED (emergency department) doctor assessed for 2 hours. No evidence of tongue swelling, hemodynamics was normal. Outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the close temporal relationship and the description of the events, itchy throat/ tongue reaction there is a reasonable possibility that the events are related to BNT162 vaccine. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-2020500303 Same reporter, product, and event, different patient
Could not lift arm for at least 2 days & sore for longer than that. Flu like symptoms - headache, muscle aches for 2 days - never has had reaction with regular strength in past.
Redness around near injection cite on left shoulder, not painful, a littler tender. Now 2 days
Received Booster 11/2021 and noted itchy rash on most of body from neck down 12/2021 Went to an Urgent Care and was given oral antibiotics which seemed to worsen rash symptoms.  Was also given a topical medication but is unsure of the name of medication. Went to PCP Mid February and was given oral steroids which did improve but not resolve symptoms. Taking oral Benadryl since 12/2021 but Denies any other OTC or oral medicaions.
Pt recv vax on 1/26/99; on 1/28/99 pt exp rash & fever
Patient arm swollen from shoulder to elbow; heated to touch and uncomfortable. Given Allegra 180mg PO.
Grandmother called and states child has a rash over his entire body and is hoarse. She denies any temperature but he has a decreased appetite. Instructed mom to come to health dept. or MD. Grandmother took child to MD and she confirmed that the rash was from immunization.
The patient has dementia and she was not sure what vaccine she needs, she asked me to check with her husband since he is more aware of the situation and knows better. The husband wanted me to give the patient the Covid vaccine and the flu vaccine at the same time. I did not check the system (Immunization Information system) due to the busy workflow in the flu clinic event. After that, I was checking the patient's system and found out that her last dose of the Covid vaccine was on 09-05-2023 which is less than 8 weeks based on the CDC recommendations.  We tried to call the patient's husband and educate them about the stronger side effects that might happen, but the husband did not respond. We will continue on trying to call them and see if any adverse reactions has happened.
Narrative: 03/08 COVID vaccine dose #1 03/09: Pt reported experiencing dizziness since yesterday, reports left ear feels clogged, dizziness, headache, abdominal and joint pain at level (8)."Pt seen in non-Facility Er. 03/15: Pt reported that while in ER, found to have vertigo and vomiting for 8-9 hours, high blood pressure 170/102, can't walk without tipping, slightly nauseous of and off high BP. left ear still plugged. found to have fluid in the ear and treated with prednisone, no antibiotic. hearing diminished due to clogging.
Pt received Pfizer for first dose (date 4/28/2021) and then she received Moderna as dose #2 (date 5/25/2021). She reports that she is feeling fine, not experiencing any adverse reactions after receiving Moderna. Informed her that we would fill out a VAERS report, in addition she was informed that we would not repeat second dose and that she is now fully vaccinated. She was  instructed  to call Health Department with any questions/concerns. She states understanding.
09/22/2022: 24 hours after injection - Redness around the injection site and felt a little tired. Rested and took ibuprofen. No other medical treatment.  09/26/2022: Noticed that one side of my face was swollen including my left eyelid. Some redness to the outer corner of left eye. Did not notice any pain but felt pressure from the swelling on the left side of my face. No discharge or change to vision. May have started the day before, but may not have been significant enough to notice and did not look in the mirror on 09/25/2022 to really notice.   09/27/2022: Swelling increased on left side of the face. Additional redness to the left side of eye. Some pain associated with movement of eye. No discharge. Eyes are slightly watery. Some change to vision. Visited the Ophthalmologist who prescribed Amoxicillin 875 mg tablet and Neomyc-Polym-Dexam eye ointment.  09/28/2022: Increased swelling. No increase in redness on eye. Same pain level associated with eye movement. No discharge. Eyes are slightly watery.  09/29/2022: Increased swelling. Increased pain level associated with eye movement. More pressure felt on left side of the face. Primarily against the nose, cheek, and temple. No discharge. Difficult to see out of the eye. At times, it feels like there is a gritty texture on the interior of the lid. Ophthalmologist prescribed Moxifloxacin 400 mg. Directed me to stop using Amoxicillin 875 mg tablet and Neomyc-Polym-Dexam eye ointment.  09/30/2022: Eye almost completely shut. Increased swelling. Increased pain level associated with eye movement. 4/10. More pressure felt on left side of the face. Primarily against the nose, cheek, and temple. No discharge. Difficult to see out of the eye. Went to the ER.   10/01/2022: Slight improvement in swelling on eyelid. Redness increased throughout the eye. Pressure still felt around the eye, by nose, and temple. Pain level the same. 4/10 No discharge. Difficult to see out of the eye. Admitted to the hospital.  Recommended Dosing: Loading dose vancomycin 2000mg X1 followed by Vancomycin 1000mg q12h starting at 10/01/22 1700  10/02/2022: Slight improvement on eyelid swelling. Decreased redness on eye. Pressure still felt around the eye, by nose, and temple. Slight improvement on pain level. 3/10 No discharge. Discharged from the hospital.  Began new antibiotic: Doxycycline hyclate 100 mg capsule.  10/03/2022 - 10/07: No significant changes to swelling. 10/08: Swelling improved with prednisone treatment. Current: Swelling improved with prednisone treatment and will continue for another 4 weeks.  Preseptal/preorbital cellulitis  Referred to rheumatologist due to IgG4 positive test.